Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01528137
Recruitment Status : Terminated (Negative data from another trial led to termination of this trial by sponsor.)
First Posted : February 7, 2012
Last Update Posted : August 2, 2016
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Agennix
Information provided by (Responsible Party):
Heather Wakelee, Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 2012
  Actual Study Completion Date : July 2013